8th Annual Medical Communications & Dissemination of Scientific Information Conference

May 2019 | Boston, MA
Request Invitation

WE GUARANTEE 100% PRIVACY, YOUR INFORMATION WILL NOT BE SHARED

“I thought the conference was excellent!  Having a conference tailored to one discipline made each panel and contact relevant.”

Director, Compliance & Legal Affairs
Orexigen

“Great insight to hear payer perspective in contracting and account management and the changing healthcare landscape.”

Channel Liaison
Biogen

“It was definitely an excellent well-rounded opportunity to meet new people, get new ideas, and get an in-depth education on what’s to come with the FDA collaborations.”

Quality Engineer
Centurion Medical Products

“It was very well organized event and high quality, the fact to have an IVD track was also interesting. Thanks, I will recommend the Q1 event!”

Regulatory Affairs – EMEA Regional Head
BIOMERIEUX

“The organization and support staff were fantastic! I’m looking forward to next year.”

Global Business Project Lead
Genentech

About the Conference:

In a highly competitive landscape, pharmaceutical and biotechnology corporations must create and disseminate a unique and impactful medical and scientific message, crafted in a way that illuminates the value of new and existing therapeutic products. With this honed message, medical communications teams must also disseminate the message using an increasingly expansive array of channels, from traditional print and journal messaging, trade-show and CME courses, as well as through online and digital channels to ensure target healthcare professionals, patients and caregivers recognize the potential impact and value of potential treatments.

Topics to Be Addressed:

  • Ensuring Message Consistency in Scientific Communication Platforms
  • Use of Marketing & Branding in Congress Planning & Execution
  • Development of Annual Medical Communication Strategic Plans
  • New Technologies, Channels & Opportunities in Medical Communications
  • Deep Focus on Innovative Methods & Strategies for Scientific Dialogue

Program Highlights:

  • Multiple Breakout Sessions Based on Company Size
  • Attendee Roster Including Detail on Therapeutic Areas
  • Stakeholder Perspectives including Patient Groups

Audience

75 Attendees

All attendees come directly from life science companies

Distinguished Presenters

Speaker recruitment in process

Networking

Networking time is built into the agenda to allow industry peers to connect and exchange ideas

Open Dialogue and Group Share

Each presentation is followed by 10-15 minutes of open dialogue for questions and exchange of best practices

Share This